BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16862482)

  • 1. Optimal treatment of premature ovarian failure after treatment for Hodgkin's lymphoma is often withheld.
    Verschuuren SI; Schaap JJ; Veer MB; Stijnen T; Burger CW; Ansink AC
    Acta Obstet Gynecol Scand; 2006; 85(8):997-1002. PubMed ID: 16862482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.
    Nitzschke M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; von Wolff M
    Arch Gynecol Obstet; 2010 Jul; 282(1):83-8. PubMed ID: 19967405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
    Franke HR; Smit WM; Vermes I
    Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous pregnancies despite failed attempts at ovulation induction in a woman with latrogenic premature ovarian failure.
    Menashe Y; Pearlstone AC; Surrey ES
    J Reprod Med; 1996 Mar; 41(3):207-10. PubMed ID: 8778425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
    Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
    Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
    Blumenfeld Z
    Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
    van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
    J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian function in adolescent women following successful treatment for non-Hodgkin's lymphoma.
    Green DM; Yakar D; Brecher ML; Lindsay AN; Voorhess ML; MacGillivray MH
    Am J Pediatr Hematol Oncol; 1983; 5(1):27-31. PubMed ID: 6407351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preservation of ovarian function in 2 young women with Hodgkin disease by laparoscopic transposition of the ovaries prior to abdominal irradiation].
    Tinga DJ; Dolsma WV; Tamminga RY; van der Zee AG
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):308-12. PubMed ID: 10221088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal replacement therapy after stem cell transplantation.
    Piccioni P; Scirpa P; D'Emilio I; Sora F; Scarciglia M; Laurenti L; De Matteis S; Sica S; Leone G; Chiusolo P
    Maturitas; 2004 Dec; 49(4):327-33. PubMed ID: 15531129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of ovarian function in young woman with hodgkin disease by laparoscopic medial transposition before abdominal irradiation.
    Solà V; Ricci P; Baeza MR; Lema R; Pardo J
    Surg Laparosc Endosc Percutan Tech; 2008 Aug; 18(4):423-5. PubMed ID: 18716550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic medial oophoropexy prior to radiation therapy in an adolescent with Hodgkin's disease.
    Scott SM; Schlaff W
    J Pediatr Adolesc Gynecol; 2005 Oct; 18(5):355-7. PubMed ID: 16202940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients.
    Huser M; Crha I; Ventruba P; Hudecek R; Zakova J; Smardova L; Kral Z; Jarkovsky J
    Hum Reprod; 2008 Apr; 23(4):863-8. PubMed ID: 18258763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female reproductive potential after treatment for Hodgkin's disease.
    Horning SJ; Hoppe RT; Kaplan HS; Rosenberg SA
    N Engl J Med; 1981 Jun; 304(23):1377-82. PubMed ID: 7231460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hodgkin's disease, fertility and pregnancy].
    Larguèche K; Laârif Z; Ferchiou M
    Rev Med Brux; 2009; 30(3):170-6. PubMed ID: 19642488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.